Life Sciences
Home >> Views >> Life Sciences
Controllers Up Stakes In Fosun Pharma, Hongbaoli
Source:CCMR   Data:2012-2-10

Nanjing Hongbaoli Corporation (002165) and Shanghai Fosun Pharmaceutical (Group) (600196) announced share buy backs by major shareholders, reports Shanghai Securities News, citing a company filing.

Jiangsu Baoyuan Investment, the largest shareholder of Hongbaoli, purchased 527,000 shares, or a 0.19 percent stake, at an average price of 11.24 yuan per share as it is optimistic about the future development prospects of the listed company.

Fosun Pharma said Fosun Group purchased 824,000 shares, or a 0.04 percent interest, yesterday. This brings the total shareholding of Fosun Group to 48.1 percent.

Fosun Group plans to up its stake by up to two percent within the next one year.


Related Hot
Copyright © 2012-2020  策点调研公司 | Ceidea | China Ceidea Market Research Co., LTD  Inc. All rights reserved.
Add:No. 2, Jiapin Second Street, Shatou Street, Panyu District, Guangzhou City, Building 1, Room 1805 Tel:+86 13503051005 sandy 
 粵ICP备13082131号-8